Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

Clinical trial NCT03202446 · TERMINATED

Trial details

NCT number: NCT03202446
Sponsor: Eske Corporation S.A.C
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Stage IV

Start date: 2016-06-13
Primary completion: 2018-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.